Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Apollo Endosurgery, Inc. (APEN : NSDQ)
 
 • Company Description   
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.

Number of Employees: 107

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.11 Daily Weekly Monthly
20 Day Moving Average: 149,452 shares
Shares Outstanding: 40.25 (millions)
Market Capitalization: $165.43 (millions)
Beta: 2.26
52 Week High: $10.39
52 Week Low: $3.70
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.40% -21.86%
12 Week -23.89% -19.87%
Year To Date -51.25% -43.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300
-
AUSTIN,TX 78746
USA		 ph: 512-279-5100
fax: 858-678-0900		 ir@apolloendo.com http://www.apolloendo.com
 
 • General Corporate Information   
Officers
Charles McKhann - Chief Executive Officer and Director
John Barr - Chairman
Jeffrey Black - Chief Financial Officer; Treasurer and Secretary
Chrissy Citzler-Carr - Controller
Julie Shimer - Director

Peer Information
Apollo Endosurgery, Inc. (ABMD)
Apollo Endosurgery, Inc. (DMDS)
Apollo Endosurgery, Inc. (CPWY.)
Apollo Endosurgery, Inc. (EQUR)
Apollo Endosurgery, Inc. (ECIA)
Apollo Endosurgery, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 03767D108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 40.25
Most Recent Split Date: 12.00 (0.18:1)
Beta: 2.26
Market Capitalization: $165.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.21 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.83 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 7.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.01
Price/Cash Flow: -
Price / Sales: 2.51
EPS Growth
vs. Year Ago Period: -23.53%
vs. Previous Quarter: 22.22%
Sales Growth
vs. Year Ago Period: 20.24%
vs. Previous Quarter: 3.04%
ROE
03/31/22 - -95.87
12/31/21 - -148.35
09/30/21 - -589.59
ROA
03/31/22 - -28.35
12/31/21 - -28.13
09/30/21 - -23.95
Current Ratio
03/31/22 - 7.78
12/31/21 - 7.92
09/30/21 - 3.62
Quick Ratio
03/31/22 - 6.83
12/31/21 - 7.09
09/30/21 - 2.86
Operating Margin
03/31/22 - -43.31
12/31/21 - -39.19
09/30/21 - -29.80
Net Margin
03/31/22 - -43.31
12/31/21 - -39.19
09/30/21 - -29.80
Pre-Tax Margin
03/31/22 - -42.88
12/31/21 - -38.94
09/30/21 - -29.34
Book Value
03/31/22 - 1.37
12/31/21 - 1.55
09/30/21 - 0.00
Inventory Turnover
03/31/22 - 2.45
12/31/21 - 2.51
09/30/21 - 2.48
Debt-to-Equity
03/31/22 - 0.97
12/31/21 - 0.87
09/30/21 - -
Debt-to-Capital
03/31/22 - 49.13
12/31/21 - 46.39
09/30/21 - -
 

Powered by Zacks Investment Research ©